Taurine Cardiovascular Health Meta-analysis: What the Evidence Says

Quick Answer

Taurine Cardiovascular Health Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 1 systematic review, 1 preclinical study.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• Higher risk is associated with female sex, advanced age, smoking, elevated body mass index, multimorbidity, and greater acute disease severity. [Wang Kaiming (2026); evidence level 1]
• Although the overall risk of PASC complications has declined over time, many individuals continue to grapple with persistent neurological, pulmonary, cardiovascular, metabolic, and gastrointestinal disorders years beyond their initial infection. [Wang Kaiming (2026); evidence level 1]
• For example, statistics from the 2022/23 UEFA Champions League season revealed that when the match temperature was ≥21 °C, both total distance covered and high-speed running distance were markedly lower than in matches played at 6-10 °C, with sprint frequency also reduced. [Dai Xincheng (2026); evidence level 4]
• In hot environments, increased skin blood flow and heavy sweating facilitate heat dissipation; however, if fluid and electrolyte replacement is insufficient, dehydration and electrolyte imbalance occur, leading to reductions in plasma volume, decreased cardiac output, and elevated heart rate, thereby increasing cardiovascular strain. [Dai Xincheng (2026); evidence level 4]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For taurine cardiovascular health meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Wang Kaiming (2026). Taurine supplementation as a therapeutic strategy for cellular senescence and chronic inflammation in long COVID: a systematic review and meta-analysis. DOI: 10.1186/s12879-026-13009-y. PMCID: PMC13085605. PMID: 41803812. License: https://creativecommons.org/licenses/by-nc-nd/4.0/ http://creativecommons.org/licenses/by-nc-nd/4.0/ This article is .... https://pmc.ncbi.nlm.nih.gov/articles/PMC13085605/
• Dai Xincheng (2026). Nutritional Strategies to Support Performance Maintenance and Recovery in Football Under Hot Environmental Conditions: A Narrative Review. DOI: 10.3390/nu18111695. PMCID: PMC13259307. PMID: 42280339. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13259307/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.